0.00Open0.02Pre Close0 Volume5 Open Interest99.00Strike Price0.00Turnover495.32%IV17.41%PremiumOct 4, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0104Delta0.0048Gamma4217.00Leverage Ratio-1.0087Theta0.0000Rho43.78Eff Leverage0.0003Vega
Dollar General Stock Discussion
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
No comment yet